Imaging to Monitor Treatment Response in Patients With Advanced Neuroendocrine Tumors

Another episode in the expert opinion series.  I thought this might be useful for some of you after an interesting ‘google alert’ brought up these discussions.  It comprises a roundtable discussion with known NET specialists and some big hitters too.  “Dr Thor” is a favourite of mine.

Worth pointing out that Dr Thor is giving is own view on this and that view may not be the same as your own doctor and/or hospital in terms of frequency and type of imaging devices used.  Nonetheless, his opinions are always interesting. Also, worth pointing out this is based on “advanced” NETs, e.g. metastatic cases and is mainly focussed on gastroenteropancreatic (GEP) NETs, particularly small intestine and pancreatic.

Thorvadur R. Halfdanarson MD from Mayo Rochester (and at the time of writing, President of NANETS)

The discussion is centred on the following statement and question

Image-based monitoring for patients with advanced neuroendocrine tumors (NETs) can be individualized based on the NET site and tumor characteristics. Emerging strategies may add to existing monitoring capabilities. 

Imaging to Monitor Treatment Response in Patients With Advanced Neuroendocrine Tumors

Patient Care Perspectives by Thorvadur R. Halfdanarson, MD

Click on the blue link below to read the discussion

Expert Perspectives | Imaging to Monitor Treatment Response in Patients With Advanced Neuroendocrine Tumors – Expert Perspectives

Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.

Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.

Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Click here and answer all questions to join my private Facebook group

Thanks for reading.

Ronny

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

Please Share this post for Neuroendocrine Cancer awareness and to help another patient